A Phase I, Open-Label, Single-Centre Study to Assess Absorption, Distribution, Metabolism and Excretion (ADME) After [14C]-Labelled Oral Administration of NKTR-118 to Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Naloxegol (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- 29 Sep 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 29 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.